302440.KS
SK bioscience Co.,Ltd.
KSC · Healthcare · Biotechnology · KR
KRW 36,250.00
+0.14%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 4.05x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.62x
- Price / sales
- 4.30x
- Price / cash flow
- 3111.86x
Enterprise value
- Enterprise value
- KRW 2.81T
- EV / sales
- 4.26x
- EV / EBITDA
- -22.34x
- EV / EBIT
- -17.91x
- Market cap
- KRW 2.84T
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026